RecruitingNCT06710067
Urine Metabolites in the Diagnosis of Disease
Studying Overgrowth syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Luventix, Inc.
- Principal Investigator
- John Spinosa, MD, PhDLuventix, Inc.
- Enrollment
- 1250 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (4)
- Unio Health Partners (Gastroenterology), Encinitas, California, United States
- Digestive Health Associates, Santa Monica, California, United States
- Westside Gastro Care, Santa Monica, California, United States
- Bass Medical Group (Gastroenterology), Walnut Creek, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06710067 on ClinicalTrials.govOther trials for Overgrowth syndrome
Additional recruiting or active studies for the same condition.